Ghost Tree Capital, LLC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 37 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Ghost Tree Capital, LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,800,000
-55.8%
473,562
-47.6%
0.39%
-73.2%
Q4 2021$4,069,000
-3.4%
904,2250.0%1.46%
+18.3%
Q3 2021$4,214,000
-33.9%
904,2250.0%1.23%
-29.7%
Q2 2021$6,375,000
+24.1%
904,2250.0%1.75%
+45.2%
Q1 2021$5,136,000
+457.0%
904,225
+352.1%
1.21%
+488.8%
Q4 2020$922,000
+18.5%
200,0000.0%0.20%
-8.9%
Q3 2020$778,000
-92.0%
200,000
-41.2%
0.22%
-91.3%
Q2 2020$9,778,000
+295.1%
340,000
+195.7%
2.58%
+293.3%
Q1 2020$2,475,000115,0000.66%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders